Innovationskapital

Mikael Brönnegård has joined Innovationskapital as an investment director on the firm’s Healthcare & Life Sciences team and will be based at the Stockholm office. Brönnegård previously worked for Pharmacia Corporation, where he held the position of vice president of Global Medical & Scientific Affairs, Global Business Management, Peptide Hormones and Metabolic Diseases. In 1983, he graduated from the medical school at the Karolinska Institute, where he currently holds a position of associate professor, and is a specialist in pediatrics, with a focus on pediatric endocrinology and diabetes.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Nordics
• Healthcare